Search Within

Milos Dokmanovic

Formats
  1. Journal Article (6)
  2. Meeting Abstract (2)
Groups
  1. Cell Biology Program Faculty (2)
  2. GSK Faculty (2)
  3. Sloan Kettering Institute Faculty (2)
People
  1. Paul Marks (8)
  2. Gisela Venta-Perez (5)
  3. Lang Ngo (5)
  4. Weisheng Xu (5)
  5. Cathy Clarke (2)
  6. Johanna Ungerstedt (2)

More People

Years
  1. 2007 (2)
  2. 2006 (2)
  3. 2005 (4)
Publications
  1. Cancer Research (2)
  2. Proceedings of the National Academy of Sciences of the United States of America (2)
  3. Expert Opinion on Investigational Drugs (1)
  4. Journal of Cellular Biochemistry (1)
  5. Molecular Cancer Research (1)
  6. Molecular Cancer Therapeutics (1)
Publishers
  1. American Association for Cancer Research (4)
  2. National Academy of Sciences (2)
  3. John Wiley & Sons (1)
  4. Taylor & Francis Group (1)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Histone deacetylase inhibitors: Overview and perspectives
    Journal Article

    Dokmanovic, M.; Clarke, C.; Marks, P. A.
    Molecular Cancer Research (2007)

    Fulltext@MSK | Save
  • Histone deacetylase inhibitors selectively suppress expression of HDAC7
    Journal Article

    Dokmanovic, M.; Perez, G.; Xu, W.; Ngo, L.; Clarke, C.; Parmigiani, R. B.; Marks, P. A.
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save
  • Role of pro- and anti-apoptotic proteins in prostate cancer cells sensitive and resistant to histone deacetylase inhibiton induced cell death
    Meeting Abstract

    Xu, W.; Ngo, L.; Perez, G.; Dokmanovic, M.; Marks, P. A.
    Cancer Research (2006)

    Fulltext@MSK | Save
  • Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitor
    Journal Article

    Xu, W.; Ngo, L.; Perez, G.; Dokmanovic, M.; Marks, P. A.
    Proceedings of the National Academy of Sciences of the United States of America (2006)

    Fulltext@MSK | Save
  • Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitor
    Meeting Abstract

    Ungerstedt, J. S.; Sowa, Y.; Xu, W.; Shao, Y.; Dokmanovic, M.; Perez, G.; Ngo, L.; Holmgren, A.; Jiang, X.; Marks, P. A.
    Cancer Research (2005)

    Fulltext@MSK | Save
  • Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors
    Journal Article

    Ungerstedt, J. S.; Sowa, Y.; Xu, W. S.; Shao, Y.; Dokmanovic, M.; Perez, G.; Ngo, L.; Holmgren, A.; Jiang, X.; Marks, P. A.
    Proceedings of the National Academy of Sciences of the United States of America (2005)

    Fulltext@MSK | Save
  • Histone deacetylase inhibitors: Discovery and development as anticancer agents
    Journal Article

    Marks, P. A.; Dokmanovic, M.
    Expert Opinion on Investigational Drugs (2005)

    Fulltext@MSK | Save
  • Prospects: Histone deacetylase inhibitors
    Journal Article

    Dokmanovic, M.; Marks, P. A.
    Journal of Cellular Biochemistry (2005)

    Fulltext@MSK | Save